The China Laparoscopic Right Hemicolectomy SNAPSHOT

Last updated: June 28, 2022
Sponsor: Beijing Friendship Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Colorectal Cancer

Colon Cancer

Treatment

N/A

Clinical Study ID

NCT04628182
BFH SNAPSHOT
  • All Genders

Study Summary

The main objective is to explore the current practice of right hemicolectomy for colon cancer located in the ascending colon and hepatic flexure in selected Chinese high quality and high volume centres. This study will identify a potential area to improve the level of standard care and serve as a reference cohort to which planned standardization and addition of innovative aspects can be compared to

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Segmental right sided hemicolectomy (including extended)
  • Cancer stage 1-3 (CT-staged)
  • No prior abdominal surgery

Exclusion

Exclusion Criteria:

  • Stage cT4b, perforated disease
  • Acute obstruction
  • Emergency surgery
  • Right hemicolectomy or ileocaecal resection as part of a large procedure such assubtotal colectomy or panproctocolectomy
  • Patients with inflammatory bowel disease (Crohn's disease or ulcerative colitis)

Study Design

Total Participants: 1579
Study Start date:
September 01, 2021
Estimated Completion Date:
June 30, 2022

Connect with a study center

  • Beijing Friendship Hospital

    Beijing, Beijing 100050
    China

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.